Little is known about racial differences in lipoprotein [a] (Lp[a]) concentrations and apolipoprotein[a] (apo[a]) phenotypes. Lp[a] protein concentrations were determined by a double monoclonal antibody enzyme-linked immunosorbent assay method in 4165 Caucasian and African American men and women from four US communities. Apo[a] phenotypes were determined by polyacrylamide gel electrophoresis and immunoblotting on a random subset of these participants (n=690). The distribution of Lp[a] protein levels in Caucasians was highly skewed (mean, 6.9 mg/dL; median, 3.7 mg/dL). In contrast, the distribution in African Americans was less skewed (mean, 13.0 mg/dL; median, 11.6 mg/dL), and Lp[a] protein levels were approximately double those in Caucasia...
Background Lp(a) (lipoprotein(a)) is the major lipoprotein carrier of oxidized phospholipids (OxPL) ...
Bovet P (Clinical Epidemiology Unit, Institute of Social and Preventive Medicine, University of Laus...
Lipoprotein(a) (Lp(a)) is a cardiovascular disease (CVD) risk factor, where inflammation impacts lev...
ObjectivesLipoprotein(a), Lp(a), represents an apolipoprotein (apo) B-carrying lipoprotein, yet the ...
SummaryThe distributions of plasma lipoprotein(a), or Lp(a), levels differ significantly among ethni...
Apolipoprotein E phenotype (APOE phenotype) has been demonstrated to be a genetic determinant of car...
Several epidemiological studies have established that elevated serum lipoprotein (a) [Lp(a)] levels ...
The distributions of plasma lipoprotein(a), or Lp(a), levels differ significantly among ethnic group...
Heritability of LPA allele, apo(a) isoform sizes, and isoform-associated lipoprotein(a) [Lp(a)] leve...
Lipoprotein(a) is an atherogenic lipoprotein which has been studied predominantly in white populatio...
Lower levels of plasma apolipoprotein (apo) A-l and higher levels of apoB, lipoprotein(a) (Lp(a)), a...
BACKGROUND. Epidemiological data on serum lipoprotein(a) (Lp(a)), a presumably strong risk factor fo...
ContextInhibition of proprotein convertase subtilisin/kexin type 9 (PCSK9) reduces lipoprotein(a) [L...
Lipoprotein(a) (Lp(a)) is an important causal cardiovascular risk factor, with serum Lp(a) levels pr...
Objective. To investigate the lipoprotein (a) (Lp (a)) levels and apolipoprotein (a) (apo (a)) pheno...
Background Lp(a) (lipoprotein(a)) is the major lipoprotein carrier of oxidized phospholipids (OxPL) ...
Bovet P (Clinical Epidemiology Unit, Institute of Social and Preventive Medicine, University of Laus...
Lipoprotein(a) (Lp(a)) is a cardiovascular disease (CVD) risk factor, where inflammation impacts lev...
ObjectivesLipoprotein(a), Lp(a), represents an apolipoprotein (apo) B-carrying lipoprotein, yet the ...
SummaryThe distributions of plasma lipoprotein(a), or Lp(a), levels differ significantly among ethni...
Apolipoprotein E phenotype (APOE phenotype) has been demonstrated to be a genetic determinant of car...
Several epidemiological studies have established that elevated serum lipoprotein (a) [Lp(a)] levels ...
The distributions of plasma lipoprotein(a), or Lp(a), levels differ significantly among ethnic group...
Heritability of LPA allele, apo(a) isoform sizes, and isoform-associated lipoprotein(a) [Lp(a)] leve...
Lipoprotein(a) is an atherogenic lipoprotein which has been studied predominantly in white populatio...
Lower levels of plasma apolipoprotein (apo) A-l and higher levels of apoB, lipoprotein(a) (Lp(a)), a...
BACKGROUND. Epidemiological data on serum lipoprotein(a) (Lp(a)), a presumably strong risk factor fo...
ContextInhibition of proprotein convertase subtilisin/kexin type 9 (PCSK9) reduces lipoprotein(a) [L...
Lipoprotein(a) (Lp(a)) is an important causal cardiovascular risk factor, with serum Lp(a) levels pr...
Objective. To investigate the lipoprotein (a) (Lp (a)) levels and apolipoprotein (a) (apo (a)) pheno...
Background Lp(a) (lipoprotein(a)) is the major lipoprotein carrier of oxidized phospholipids (OxPL) ...
Bovet P (Clinical Epidemiology Unit, Institute of Social and Preventive Medicine, University of Laus...
Lipoprotein(a) (Lp(a)) is a cardiovascular disease (CVD) risk factor, where inflammation impacts lev...